WASHINGTON (NewsNation) — The federal government said the national stockpile is full with ventilators, and has canceled its remaining orders.
The Department of Health and Human Services signed nearly $3 billion in emergency contracts as COVID-19 cases began to rise in the spring.
They issued a statement Tuesday affirming that the national stockpile has now reached its maximum capacity for the life-saving breathing machines, with nearly 120,000 available for deployment to state and local health officials if needed.
Though the orders were billed as a cost-saving measure, Democrats said the cancellations show the White House vastly overspent in its quest to fulfill President Donald Trump’s pledge to make the United States the “King of Ventilators.”
“By terminating the remainder of deliveries from these contracts, HHS is balancing federal stockpile requirements with commercial market demand for ventilators,” said Carol Danko, an agency spokesperson. “As a result, HHS is saving the U.S. taxpayer millions of dollars by halting delivery of additional ventilators that are no longer required.”
The agency didn’t have an estimate for how much taxpayers would save by canceling the contracts because the terms and potential penalties for the early terminations were still being negotiated with the companies involved.
HHS confirmed it was terminating contracts with ventilator manufacturers Hamilton Medical and Vyaire Medical, which will result in the reduction of 38,000 ventilators that had been scheduled for delivery to the National Strategic Stockpile by the end of 2020.
An agency spokesperson declined to comment on the status of its largest ventilator contract, a $647 million deal with Philips that is now the subject of an internal HHS investigation and legal review.
But Steve Klink, a spokesman for Philips at the company’s headquarters in Amsterdam, confirmed that its contract had also been canceled and that it will not deliver the remaining 30,700 ventilators on its order to the U.S. stockpile.
Klink said HHS had not yet given the company any “formal reason” for the cancellation.
“Unlike typically in the private sector, the U.S. government does not need any reason to terminate an agreement,” Klink said. “We can confidently say that we have delivered on our commitments. While we are disappointed in light of our massive efforts, we will work with HHS to effectuate the partial termination of this contract.”
The Philips contract has been under scrutiny because the company had signed a 2019 agreement to deliver 10,000 basic emergency ventilators to the national stockpile by 2022 at a cost of about $3,280 each. But once the COVID pandemic hit, the company inked a new deal with the Trump administration to provide 43,000 of its more complicated and expensive hospital-grade models at an average cost of about $15,000 each.
The company has said it still plans to deliver the 10,000 low-cost ventilators over the next two years under its earlier contract.
House Democrats said they would expand their probe into the White House’s handling of the Phillips contract, which they said was negotiated by Trump trade adviser Peter Navarro.
“American taxpayers deserve to have their money well spent,” said Rep. Raja Krishnamoorthi, chairman of the House Subcommittee on Economic and Consumer Policy. “Incompetent negotiations by top Trump Administration officials, like Peter Navarro, wasted hundreds of millions of taxpayer dollars.”
White House deputy press secretary Sarah Matthews said Navarro “played a vital role in our coronavirus response” by helping oversee federal contracts that helped create thousands of jobs.
“While the Trump Administration has been focused on saving lives, House Democrats continue to focus on pointless investigations,” Matthews said.
As the virus took hold and began to spread across the U.S. in March, governors and mayors of big cities urged President Donald Trump to use his authority under the Defense Production Act to direct private companies to ramp up production of ventilators. At the time, the national stockpile had only about 16,660 ventilators ready to deploy.
During the month of April, HHS issued emergency contracts to established ventilator companies, as well as U.S. automakers Ford and General Motors.
By the time the new machines were being delivered to the stockpile in the early summer, some doctors were moving away from the widespread use of ventilators in all but the most critically ill COVID-19 patients due to higher death rates for those put on the machines. Studies still aren’t conclusive on how effective they are in survival of COVID-19.
GM said Tuesday it has finished making all 30,000 ventilators under its $489 million contract. Ford announced earlier it had finished making 50,000 ventilators for the government at a cost of $336 million.
Reporting by Michael Biesecker/AP